Endotracheal intubation is associated with hemodynamic response that may
be serious in high-risk patients. This study compared oral gabapentin 900 mg alone or
with 7.5 mg oral midazolam on the hemodynamic responses to direct laryngoscopy and
endotracheal intubation (LETI).
Methodology: This randomized, double-blind clinical trial was conducted in operating
room complex, National Cancer Institute, Cairo University, Cairo. The study included
60 normotensive adults scheduled for modified radical mastectomy under general
anesthesia. The participants were randomly allocated to two equal groups to receive
premedication either with oral gabapentin 900 mg (Group G) or gabapentin 900 mg
plus 7.5 mg midazolam (Group GM).
Sedation was monitored up to the time of induction of anesthesia. Heart rate (HR) and
systolic and diastolic blood pressures were recorded up to 30 min of laryngoscopy.
Results: In the two groups, systolic and diastolic blood pressure and heart changes
were controlled up to 30 min intra-operatively. Systolic and diastolic blood pressure
were significantly lower in Group GM compared to Group G. At all times, there was no
significant difference in heart rate between the two groups.
Conclusion: Oral gabapentin is effective in attenuation of the hypertensive response to
laryngoscopy and endotracheal intubation when administered in a dose of 900 mg 90
min before modified radical mastectomy. It is more effective when combined with oral
midazolam 7.5 mg.